Exelixis saw the highest growth of 1.99% in patent filings and 2.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Exelixis‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Exelixis has been focused on protecting inventions in United States(US) with ten publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 47% filings and 33% grants. The United States(US), Australia(AU), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Exelixis is filings its patents. Among the top granted patent authorities, Exelixis has 33% of its grants in United States(US), 33% in China(CN) and 22% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for Exelixis
Patents related to rare diseases and climate change lead Exelixis's portfolio
Exelixis has the highest number of patents in rare diseases followed by, climate change and cell & gene therapy. For rare diseases, nearly 57% of patents were filed and 75% of patents were granted in Q2 2024.
Kidney cancer (renal cell cancer) related patents lead Exelixis portfolio followed by prostate cancer, and carcinomas
Exelixis has highest number of patents in kidney cancer (renal cell cancer) followed by prostate cancer, carcinomas, mobiles, hand-helds, pdas, smartphones, and metastatic transitional (urothelial) tract cancer. For kidney cancer (renal cell cancer), nearly 4% of patents were filed and 10% of patents were granted in Q2 2024.
For comprehensive analysis of Exelixis's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
